Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Bacterial activity in child's mouth may serve as biomarkers for autism spectrum disorder

Bacterial activity in child's mouth may serve as biomarkers for autism spectrum disorder

Study shows link between thinning of the retina and early sign of Parkinson's disease

Study shows link between thinning of the retina and early sign of Parkinson's disease

Scientists explore ways for drug therapies to reach deadly brain tumors

Scientists explore ways for drug therapies to reach deadly brain tumors

Magnetic gene in aquarium fish could open doors to treatment for epilepsy, Parkinson's

Magnetic gene in aquarium fish could open doors to treatment for epilepsy, Parkinson's

Reduced levels of chaperone protein may have implications for development of Parkinson’s disease

Reduced levels of chaperone protein may have implications for development of Parkinson’s disease

Biomarkers responsible for exhaustion in cancer linked to fatigue in Parkinson's disease

Biomarkers responsible for exhaustion in cancer linked to fatigue in Parkinson's disease

Researchers study use of MRI-guided focused ultrasound to open blood-brain barrier

Researchers study use of MRI-guided focused ultrasound to open blood-brain barrier

Atlas of the nervous system provides new clues about origin of neurological diseases

Atlas of the nervous system provides new clues about origin of neurological diseases

New guideline released to improve diagnosis, care for people with prolonged disorders of consciousness

New guideline released to improve diagnosis, care for people with prolonged disorders of consciousness

Silencing of GULP1 gene expression plays important role in ovarian carcinogenesis

Silencing of GULP1 gene expression plays important role in ovarian carcinogenesis

Insulin resistance largely undetected in non-diabetic patients with Parkinson's disease

Insulin resistance largely undetected in non-diabetic patients with Parkinson's disease

New study uses metabolomics to compare lipid profiles of infant formulas and human milk

New study uses metabolomics to compare lipid profiles of infant formulas and human milk

Folic acid may prevent language delays in children of mothers with epilepsy

Folic acid may prevent language delays in children of mothers with epilepsy

New treatment may be on the horizon for Parkinson's disease

New treatment may be on the horizon for Parkinson's disease

Exenatide treatment improves depression symptoms in PD patients

Exenatide treatment improves depression symptoms in PD patients

Qualification of first Parkinson's biomarker represents major milestone in clinical trials

Qualification of first Parkinson's biomarker represents major milestone in clinical trials

No gaps in understanding: Here’s your primer on Medigap coverage

No gaps in understanding: Here’s your primer on Medigap coverage

New sensor detects early-stage Parkinson's disease from the breath of patients

New sensor detects early-stage Parkinson's disease from the breath of patients

Disrupted transportation routes in nerve cells are main cause of Parkinson's disease

Disrupted transportation routes in nerve cells are main cause of Parkinson's disease

Parkinson's therapies being developed may benefit everybody with the disease

Parkinson's therapies being developed may benefit everybody with the disease